KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.30
+10.05 (4.54%)
AAPL  260.04
+1.14 (0.44%)
AMD  234.48
+2.66 (1.15%)
BAC  52.67
+0.79 (1.53%)
GOOG  316.87
+2.13 (0.68%)
META  633.55
+21.13 (3.45%)
MSFT  372.70
-1.63 (-0.44%)
NVDA  183.75
+1.67 (0.92%)
ORCL  137.68
-5.48 (-3.83%)
TSLA  347.35
+4.10 (1.19%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.